Log in
Enquire now
‌

US Patent 11957876 Glucose control system with automated backup therapy protocol generation

Patent 11957876 was granted and assigned to Beta Bionics, Inc. on April, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Beta Bionics, Inc.
Beta Bionics, Inc.
0
Current Assignee
Beta Bionics, Inc.
Beta Bionics, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119578760
Patent Inventor Names
Michael J. Rosinko0
David Chi-Wai Lim0
Edward R. Damiano0
Firas H. El-Khatib0
Edward B. Raskin0
Date of Patent
April 16, 2024
0
Patent Application Number
172129840
Date Filed
March 25, 2021
0
Patent Citations
‌
US Patent 7655618 Compositions and methods for the prevention and control of insulin-induced hypoglycemia
0
‌
US Patent 7678762 Methods for reducing the risk of hypoglycemia
0
‌
US Patent 7678763 Compositions and methods for the prevention and control of insulin-induced hypoglycemia
0
‌
US Patent 7683027 Methods relating to hypoglycemic unawareness
0
‌
US Patent 7717903 Operating an infusion pump system
0
‌
US Patent 7766829 Method and system for providing basal profile modification in analyte monitoring and management systems
0
‌
US Patent 7806854 Fully automated control system for type 1 diabetes
0
‌
US Patent 7850641 Safety limits for closed-loop infusion pump control
0
...
Patent Citations Received
‌
US Patent D1050165 Display screen or portion thereof with graphical user interface
0
‌
US Patent D1050164 Display screen or portion thereof with graphical user interface
0
‌
US Patent D1049146 Display screen or portion thereof with graphical user interface
0
Patent Primary Examiner
‌
Manuel A Mendez
0
Patent abstract

An automated blood glucose control system is configured to generate a backup therapy protocol comprising insulin therapy instructions derived from autonomously determined doses of insulin. The system generates a dose control signal using a control algorithm configured to autonomously determine doses of insulin to be infused into a subject for the purpose of controlling blood glucose of the subject based at least in part on a glucose level signal received from a glucose sensor. The system can track insulin therapy administered to the subject over a tracking period, including storing an indication of the autonomously determined doses of insulin delivered to the subject as basal insulin, as correction boluses of insulin, or as mealtime boluses of insulin. The system can generate a backup injection therapy protocol or a backup pump therapy protocol with insulin therapy instructions based at least in part on the insulin therapy administered to the subject over the tracking period.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11957876 Glucose control system with automated backup therapy protocol generation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.